Our history Fresenius — a success story Over the past years, Fresenius has grown from a small pharmacy lab into the global health care group you know today. The Fresenius family assumes ownership in the 19th century. Eduard Fresenius, founds the pharmaceutical company Dr. He expands the pharmacy laboratory into a small manufacturing operation. Its main products are pharmaceutical specialties such as injection solutions, serologic reagents and Bormelin nasal ointment.
|Published (Last):||7 March 2010|
|PDF File Size:||11.28 Mb|
|ePub File Size:||10.28 Mb|
|Price:||Free* [*Free Regsitration Required]|
Our history Fresenius — a success story Over the past years, Fresenius has grown from a small pharmacy lab into the global health care group you know today. The Fresenius family assumes ownership in the 19th century. Eduard Fresenius, founds the pharmaceutical company Dr.
He expands the pharmacy laboratory into a small manufacturing operation. Its main products are pharmaceutical specialties such as injection solutions, serologic reagents and Bormelin nasal ointment. Fresenius devotes more and more time to the company, which grows to around employees. Wendel , Saarland. Today, Fresenius produces highly innovative Polysulfone dialyzers in St. These membranes today set the quality standards for dialyzers. Consolidated sales amount to approximately 7.
Fresenius Kabi is the European leader in the field of nutrition and infusion therapy with subsidiaries and distributors worldwide. Fresenius moves into the new head office in Bad Homburg. Fresenius has nearly 39, employees worldwide. Fresenius, a health care group with worldwide operations and over 60, employees, achieves sales of around 7.
Through its network of approximately 2, dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to approximately , patients around the globe. Fresenius Kabi enters into the North American pharmaceuticals market and becomes a globally leading company in the field of I. Fresenius Medical Care produces the ,th dialysis machine. Fresenius Kabi acquires Fenwal, thus becoming the market leader in transfusion technology.
Fresenius also passes the milestone of , employees. The index tracks the share price development of 50 large publicly traded companies, representing various economic sectors, from twelve Eurozone countries.
Sustainable product design Smooth handling The blue header with its laterally placed blood inlet port is designed to reduce the risk of kinked bloodlines, aiming at smooth handling and allowing healthcare professionals to focus on what really matters — the best care for patients. Simplified workflows The FX Dialyzers are developed for system compatibility, perfectly fitting into automatic priming procedures with low rinsing volumes and short preparation times. In addition, there is no need to turn any FX Dialyzer during the priming procedure. Moreover, the FX Dialyzers have a removable label that can easily be attached to patient records, allowing for quick documentation. Precise nanoscale modulation of pore size, structure and distribution favors minimal resistance to solute transfer across the membrane and contributes to improved clearances compared to macro-design membranes. It prevents the channelling of the dialysis fluid and ensures that each fiber within the bundle is perfectly surrounded by the dialysis fluid.
Optiflux High Flux Single-use Dialyzers